RECURRENCE OF MELANOMA FOLLOWING A NEGATIVE SENTINEL LYMPH NODE BIOPSY - A RETROSPECTIVE STUDY

• Autor(a) principal: Toda-Brito, Helena
• Data de Publicação: 2015
• Outros Autores: Rodrigues, Teresa, Tavares, Ermelindo, Parente, Joana, Martins, César, Ferreira, Luís
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• DOI: 10.29021/spdv.73.2.369
• Texto Completo: https://doi.org/10.29021/spdv.73.2.369
• topic: Melanoma; Neoplasm recurrence; local; Sentinel lymph node biopsy; Skin neoplasms; Melanoma; Neoplasias da pele; Biópsia do gânglio sentinela; Recidiva local de neoplasia

Introduction: The sentinel lymph node biopsy is an important tool for staging patients with melanoma, allowing identification of occult regional lymph node involvement and avoidance of unnecessary lymphadenectomies.Objective: To analyze the patterns of recurrence of melanoma in patients with a negative sentinel lymph node biopsy result and identify the clinical and pathological characteristics potentially predictive of recurrence after a negative sentinel lymph node biopsy.Materials and methods: A retrospective study was conducted in patients with cutaneous melanoma who underwent sentinel lymph node biopsy in the Department of Dermatology, Santarém Hospital, between 2005 and 2011.Results: 96 sentinel lymph node biopsy staged patients were evaluated. Of these, 29 patients had a positive sentinel lymph node biopsy result, 66 had a negative sentinel lymph node biopsy result and one patient had an inconclusive result. Among the 66 patients with a negative sentinel lymph node biopsy result, 11 (16.7 % of the negative results) had a recurrence of melanoma at a median of 21.7 months of follow-up (range, 8-51 months). Compared to the patients without recurrence, these patients had an older age at diagnosis (mean 71.8 vs 62.9 years; p=0.021), were predominantly of male sex (54.5% vs 29.1%; p=0,159), and had deeper primary lesions (median thickness 2.92 vs 1.80 mm; p=0.087) that were more likely to be ulcerated (63.6% vs 38.1%; p=0,177) and to have vascular/perineural invasion (40% vs 13%; p=0,207). Nodular melanoma was the most prevalent clinical variant in this group (54.5%), while in the group with recurrence prevailed the superficial spreading type (50.9%).Conclusions: Overall, recurrence of melanoma after a negative sentinel lymph node biopsy result (16.7%) was similar to that in previously reported studies. We identified as possible predictors of recurrence, despite a negative sentinel lymph node biopsy result: older age at diagnosis, male sex, higher Breslow thickness, presence of ulceration, presence of vascular/perineural invasion, and nodular variant.